Integrated Biopharma Inc (INBP) — 8-K Filings

All 8-K filings from Integrated Biopharma Inc. Browse 6 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (6)

  • 8-K Filing — Dec 1, 2025
  • Integrated Biopharma Changes Auditors — Apr 24, 2025 Risk: low
    Integrated Biopharma, Inc. filed an 8-K on April 24, 2025, to report changes in its certifying accountant. The company previously engaged WithumSmith+Brown, PC,
  • Integrated Biopharma Terminates Agreement, Enters New Deal — Apr 21, 2025 Risk: medium
    Integrated Biopharma, Inc. announced on April 15, 2025, the termination of a material definitive agreement. The company also entered into a new material definit
  • Integrated Biopharma Files 8-K — Dec 2, 2024 Risk: low
    Integrated Biopharma, Inc. filed an 8-K on December 2, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing d
  • Integrated Biopharma Files 8-K on Financials — Nov 14, 2024 Risk: low
    Integrated Biopharma, Inc. filed an 8-K on November 14, 2024, reporting on its results of operations and financial condition as of November 13, 2024. The filing
  • Integrated Biopharma Files 8-K on Operations and Financials — Sep 23, 2024 Risk: low
    Integrated Biopharma, Inc. filed an 8-K on September 23, 2024, reporting on events that occurred on September 20, 2024. The filing pertains to the company's res

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.